[ET Net News Agency, 13 August 2026] HANSOH PHARMA (03692) rose 5% to HK$35.18.
It hits an intra-day high of HK$35.18, and an intra-day low of HK$33.2. The total shares traded was 5.02 million, with a value of HK$171.15m. The active buy/sell ratio is 73:27, with net buying turnover of HK$75.24m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$10.68m, with volume weighted average price of HK$34.015. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$19.52m, with volume weighted average price of HK$34.167.
The Hang Seng Index now rose 17 points, or less than 0.1% to 25,457; the Hang Seng China Enterprises Index now fell 3 points, or less than 0.1% to 8,443.
Basic Information| Nominal | 35.180 | % Chg | +5.01% |
| High | 35.180 | Low | 33.200 |
| Shares Tr | 5.02m | Turnover | 171.15m |
| 10-D SMA | 32.914 | %H.V | 40.113 |
| 20-D SMA | 32.736 | VWAP | 34.090 |
| 50-D SMA | 31.378 | RSI14 | 63.082 |
Status: Active buy/sell ratio is 73:27, with net buying turnover of HK$75.24m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 35.180 | +5.01 |
| SIHUAN PHARM (00460) | 0.905 | +3.43 |
| GRAND PHARMA (00512) | 5.480 | +2.72 |
| SBP GROUP (01177) | 4.995 | +1.42 |
| HENGRUI PHARMA (01276) | 56.900 | +1.52 |
| LIVZON PHARMA (01513) | 26.500 | +0.68 |
| LUYE PHARMA (02186) | 2.175 | +3.33 |
| FOSUN PHARMA (02196) | 17.470 | +2.76 |
| SH PHARMA (02607) | 11.840 | +0.59 |
| CHINARES PHARMA (03320) | 4.950 | +1.12 |
(ed)
